FDA panel backs Pfizer's RSV vaccine for US adults

Published Date: 02 Mar 2023

In a tough vote, advisers to the US Food and Drug Administration (FDA) on Tuesday approved the RSV vaccine for Americans over 60.

Read Full News

Latest News

Global evidence highlights social roots of HPV vaccine hesitancy

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

Cervical cancer vaccine push has saved 1.4 million lives: Gavi

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Philadelphia airport passengers may have been exposed to measles, health officials warn

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Texas whooping cough cases reach record high, data shows

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Biovac starts trials on South Africa's first domestically developed cholera vaccine

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

Todays Updates

The Skin–Brain Axis: Emerging Evidence Transforming Dermatologic Care Lisa A. Swanson, MD, Enzo Berardesca, MD, Mohammad Jafferany, MD

Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.

Phase 2 Study of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy: The REVISE Trial Isabella Ciccone, MPH

The REVISE trial, a phase 2 study evaluating GenSight Biologics’ lenadogene nolparvovec in patients with Leber hereditary optic neuropathy, is expected to begin in January 2026.

FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials Noah Stansfield

Intellia’s trial for nex-z in ATTR-CM remains under clinical hold.

Navigating Opportunities and Obstacles in Gastroparesis, With Ronen Arai, MD Ronen Arai, MD

Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.

IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis

IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis

Todays Updates

The Skin–Brain Axis: Emerging Evidence Transforming Dermatologic Care Lisa A. Swanson, MD, Enzo Berardesca, MD, Mohammad Jafferany, MD

Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.

Phase 2 Study of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy: The REVISE Trial Isabella Ciccone, MPH

The REVISE trial, a phase 2 study evaluating GenSight Biologics’ lenadogene nolparvovec in patients with Leber hereditary optic neuropathy, is expected to begin in January 2026.

FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials Noah Stansfield

Intellia’s trial for nex-z in ATTR-CM remains under clinical hold.

Navigating Opportunities and Obstacles in Gastroparesis, With Ronen Arai, MD Ronen Arai, MD

Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.

IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis

IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis

Latest News

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

News All Time

California partnership aided COVID-19 response and health equity, report finds

The COVID-19 pandemic did not affect everyone equally. Communities of color, especially Latino (including undocumented persons), Black, and Native American groups, as well as people with low incomes, experienced much higher ...

CDC stops recommending COVID-19 shots for all, leaves decision to patients

The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.

Study: Flu vaccine uptake consistently highest for Asian patients, lowest for Black patients

Persistent racial differences in flu vaccination uptake are seen across ages and flu seasons, according to a study published in the Oct. 3 issue of Vaccine.

A middle-ground framework for US vaccine policy

In a new JAMA Viewpoint, Lainie Friedman Ross, MD, Ph.D., chair of the Department of Health Humanities and Bioethics at the University of Rochester Medical Center, and Mark Navin, Ph.D., chair of Philosophy at Oakland University, ...

Opinion: Experts warn disaster looms following politicized US health changes

Authors from the American College of Physicians (ACP) warn that disaster looms ahead for the U.S. health care system, likely precipitated by an epidemic of vaccine-preventable and attenuating diseases. They say the politicization ...

RSV vaccine uptake in pregnancy linked to perinatal outcomes and health inequities

Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal health outcomes among vaccinated women, according to research at City St George's and published ...

Chickenpox: Why the UK has approved the MMRV vaccine in under-fours but the US is preparing to restrict it

Two countries, two different approaches to protecting children from chickenpox. While the UK prepares to introduce a combined vaccine covering measles, mumps, rubella and chickenpox (MMRV) in a single jab, the US is moving ...

Despite escalating anti-vaccine rhetoric, most Americans support vaccine mandates, surveys find

At an explosive news conference on the causes of autism, President Donald Trump espoused decades-old, long-debunked theories linking autism to the childhood vaccine schedule.

Minnesota defies feds with COVID vaccine guidance

Minnesota's top doctor issued a standing order on Sept. 22 allowing pharmacists to give COVID-19 vaccines without prescriptions to a broader group of patients than federally recommended.

New vaccine panel recommends doctor consults before COVID shots

A new federal vaccine panel appointed by U.S. Health Secretary Robert F. Kennedy Jr. has recommended tighter restrictions on COVID-19 shots.

Vaccine mandates misinformation: Two experts explain the true role of slavery and racism

On Sept. 3, 2025, Florida announced its plans to be the first state to eliminate vaccine mandates for its citizens, including those for children to attend school.

Take the shot: Does the country's future hang on public health support?

The Advisory Committee on Immunization Practices recently linked 25 unverified reports of child deaths to COVID-19 vaccines as they consider further limiting access to this and other immunizations, like those for hepatitis ...

Illinois committee recommends state part ways with feds on COVID-19 vaccines

Illinois health leaders should part ways with the federal government when it comes to COVID-19 vaccines and recommend the shots for all adults and many children, an influential state committee voted Monday.

CDC advisers limit MMRV combo vaccine, delay hepatitis B vote

Top vaccine advisers hand-selected by Health Secretary Robert F. Kennedy Jr. voted Thursday to limit the use of a combination shot that protects against measles, mumps, rubella and chickenpox.

West Coast states issue their own COVID, flu, RSV vaccine rules

Four Western states are taking a different approach from the U.S. Centers for Disease Control and Prevention (CDC) on vaccines for COVID-19, flu and RSV.

US vaccine panel to hold high-stakes policy meeting

A US panel stacked with figures sympathetic to the anti-vaccine movement will on Thursday take on federal immunization recommendations in a highly politicized meeting that could upend longstanding medical advice.

Recommended News For You

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.

How cancer misinformation exploits the way we think

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.

A study on lung cancer provides additional proof of the value of screening.

Recommended Articles For You

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma 

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Exploring the Latest Treatments for Desmoid Tumors 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

2.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

3.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

4.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

5.

Beyond What Is Visible in Myelofibrosis?

1.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

2.

The benefits of using magnesium sulfate during pregnancy 

3.

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide

4.

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer

5.

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot